The decision reinstates unscientific regulation of new plant varieties, contradicting not only decades of experimentation, ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Ocugen (NASDAQ: OCGN) Q4 2024 Earnings Call Mar 05, 2025, 8:30 a.m. ET ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...

Transposons, also known as jumping genes or mobile genetic elements as they can replicate and reinsert themselves in the ...

Viruses like the one that causes COVID-19 constantly mutate, rendering many antibody treatments ineffective. A Stanford-led ...

With the biohacking conference taking place in Los Angeles later this month, we wanted to take this opportunity to explore ...

Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders.

OPGx-MERTK is a gene therapy being developed by Opus Genetics to treat patients impacted by MERTK-related retinitis pigmentosa (RP). Results from a pre-clinical study which evaluated OPGx-MERTK in a ...

Q4 2024 Earnings Call Transcript March 4, 2025 Cryoport, Inc. misses on earnings expectations. Reported EPS is $-0.42 EPS, ...

Dr. Michael Wong, Roswell Park's new physician-in-chief, brings expertise in melanoma and rare skin cancers to Buffalo's ...

Hearing impairment affects millions globally, with genetics playing a major role in infant hearing loss. Early screening and ...